Eaton Vance Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $507M | Sell |
|
|||||
|
2022
Q2 | $562M | Sell |
|
|||||
|
2022
Q1 | $535M | Buy |
|
|||||
|
2021
Q4 | $299M | Buy |
|
|||||
|
2021
Q3 | $198M | Buy |
|
|||||
|
2021
Q2 | $224M | Sell |
|
|||||
|
2021
Q1 | $213M | Sell |
|
|||||
|
2020
Q4 | $215M | Buy |
|
|||||
|
2020
Q3 | $204M | Sell |
|
|||||
|
2020
Q2 | $200M | Sell |
|
|||||
|
2020
Q1 | $350M | Sell |
|
|||||
|
2019
Q4 | $428M | Buy |
|
|||||
|
2019
Q3 | $282M | Buy |
|
|||||
|
2019
Q2 | $240M | Buy |
|
|||||
|
2019
Q1 | $119M | Sell |
|
|||||
|
2018
Q4 | $130M | Sell |
|
|||||
|
2018
Q3 | $176M | Sell |
|
|||||
|
2018
Q2 | $157M | Sell |
|
|||||
|
2018
Q1 | $378M | Buy |
|
|||||
|
2017
Q4 | $187M | Sell |
|
|||||
|
2017
Q3 | $196M | Sell |
|
|||||
|
2017
Q2 | $172M | Sell |
|
|||||
|
2017
Q1 | $173M | Sell |
|
|||||
|
2016
Q4 | $215M | Sell |
|
|||||
|
2016
Q3 | $204M | Sell |
|
|||||
|
2016
Q2 | $338M | Buy |
|
|||||
|
2016
Q1 | $251M | Sell |
|
|||||
|
2015
Q4 | $276M | Buy |
|
|||||
|
2015
Q3 | $232M | Buy |
|
|||||
|
2015
Q2 | $209M | Buy |
|
|||||
|
2015
Q1 | $191M | Buy |
|
|||||
|
2014
Q4 | $122M | Buy |
|
|||||
|
2014
Q3 | $99.7M | Buy |
|
|||||
|
2014
Q2 | $93.3M | Buy |
|
|||||
|
2014
Q1 | $99M | Sell |
|
|||||
|
2013
Q4 | $101M | Buy |
|
|||||
|
2013
Q3 | $84.2M | Buy |
|
|||||
|
2013
Q2 | $76.9M | Buy |
|